Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06083051 · ClinicalTrials.gov registry record · NA

Differences in Postoperative Symptoms With Four Ureteral Stents

A NA study of Urinary Stone, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
272
Enrollment target
1
Study location

NCT06083051 is a NA study of Urinary Stone that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 272 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06083051, a NA study of Urinary Stone, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
272 participants
Enrollment target
1
Study location

Study Summary

This is a prospective randomized controlled trial designed to assess the differences in postoperative symptoms related to placement of a 6Fr Percuflex ureteral stents, 6Fr Tria ureteral stents, 4.8Fr Percuflex ureteral stents, and 4.8Fr Tria ureteral stents after ureteroscopy with laser lithotripsy for treatment of upper tract urinary stones. 272 participants will be enrolled and will be on study for up to approximately 10 weeks.

Conditions Studied

Interventions

  • DEVICE 6Fr Percuflex ureteral stents
  • DEVICE 6Fr Tria ureteral stents
  • DEVICE 4.8Fr Tria ureteral stents
  • DEVICE 4.8Fr Percuflex ureteral stents

Study Locations (1)

Wisconsin

  • University of Wisconsin School of Medicine and Public Health - Madison

Trial Details

FieldValue
Enrollment Target 272 participants
Start Date 2024-03-21
Est. Completion 2026-12
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06083051

The ClinicalTrials.gov registry entry for NCT06083051 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urinary Stone appearing as the primary indexed condition, and to 4 interventions - of which 6Fr Percuflex ureteral stents is the first listed.

NCT06083051 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06083051 about?

NCT06083051 is a clinical study titled "Differences in Postoperative Symptoms With Four Ureteral Stents". This is a prospective randomized controlled trial designed to assess the differences in postoperative symptoms related to placement of a 6Fr Percuflex ureteral stents, 6Fr Tria ureteral stents, 4.8Fr Percuflex ureteral stents, and 4.8Fr Tria ureteral stents after ureteroscopy with laser lithotripsy ...

What is the current status of trial NCT06083051?

This trial is currently recruiting. It is a NA study. The enrollment target is 272 participants. The study started on 2024-03-21. Estimated completion is 2026-12.

What conditions does trial NCT06083051 study?

This clinical trial studies the following conditions: Urinary Stone.

What interventions are being tested in trial NCT06083051?

The interventions under investigation include: 6Fr Percuflex ureteral stents (DEVICE), 6Fr Tria ureteral stents (DEVICE), 4.8Fr Tria ureteral stents (DEVICE), 4.8Fr Percuflex ureteral stents (DEVICE).

Who is sponsoring clinical trial NCT06083051?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06083051 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Stone

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.